Specifications
Target
Alternative Names
CD8A; CD8a molecule; CD8, CD8 antigen, alpha polypeptide (p32) , T cell surface glycoprotein CD8 alpha chain; T-cell surface glycoprotein CD8 alpha chain; T8 T-cell antigen; T cell co-receptor; OKT8 T-cell antigen; T-cell antigen Leu2; Leu2 T-lymphocyte
Product Background
Antigen Description
The CD38 (Mw = 45kDa) antigen is expressed during the early stages of T and B lymphocyte differentiation and is expressed by immature B and T lymphocytes, activated B and T cells, NK lymphocytes and germinal centre B cells and plasma cells. CD8: This antigen is present on human T suppressor/cytotoxic cell subtypes, that represent 20-36% of normal peripheral blood lymphocytes, and on NK cells subset (CD3-CD8+) and thymocytes. Patients with AIDS exhibit T cell lymphopenia, a loss of CD4+ lymphocytes and a relative increase in the CD8+ subtype and in the CD3+CD4-CD8- subtype.
Pathway
Adaptive Immune System, organism-specific biosystem; Antigen processing and presentation, organism-specific biosystem; Antigen processing and presentation, conserved biosystem; Cell adhesion molecules (CAMs), organism-specific biosystem; Cell adhesion molecules (CAMs), conserved biosystem; Downstream signaling in naive CD8+ T cells, organism-specific biosystem; Hematopoietic cell lineage, organism-specific biosystem;
Citations
Publication ()
Have you cited DCABH-1395 in a publication?
Let us know and earn a reward for your research.